Logo image
Back
Contrasting epidemiology and genetic variation of Plasmodium vivax infecting Duffy-negative individuals across Africa
Journal article   Open access   Peer reviewed

Contrasting epidemiology and genetic variation of Plasmodium vivax infecting Duffy-negative individuals across Africa

Eugenia Lo, Gianluca Russo, Kareen Pestana, Daniel Kepple, Beka Raya Abagero, Ghyslaine Bruna Djeunang Dongho, Karthigayan Gunalan, Louis H. Miller, Muzamil Mahdi Abdel Hamid, Delenasaw Yewhalaw, …
International journal of infectious diseases, v 108, pp 63-71
Jul 2021
DOI: https://doi.org/10.1016/j.ijid.2021.05.009
PMID: 33991680
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.1016/j.ijid.2021.05.009View
Published, Version of Record (VoR) Open

Abstract

Duffy negative Genetic relationships Plasmodium vivax Malaria Molecular Epidemiology Sub-Saharan Africa
•Vivax malaria is spreading across Africa, causing symptomatic and asymptomatic cases.•P. vivax infections in Duffy-negative populations have low parasitemia.•Sensitive and standardized methods are needed to detect vivax malaria in Africa.•P. vivax in Duffy-negative Africans have evolved multiple times independently.•The public health significance of vivax malaria in Africa should no longer be neglected. Plasmodium vivax malaria was thought to be rare in Africans who lack the Duffy blood group antigen expression. However, recent studies indicate that P. vivax can infect Duffy-negative individuals and has spread into areas of high Duffy negativity across Africa. Our study compared epidemiological and genetic features of P. vivax between African regions. A standardized approach was used to identify and quantify P. vivax from Botswana, Ethiopia, and Sudan, where Duffy-positive and Duffy-negative individuals coexist. The study involved sequencing the Duffy binding protein (DBP) gene and inferring genetic relationships among P. vivax populations across Africa. Among 1215 febrile patients, the proportions of Duffy negativity ranged from 20–36% in East Africa to 84% in southern Africa. Average P. vivax prevalence among Duffy-negative populations ranged from 9.2% in Sudan to 86% in Botswana. Parasite density in Duffy-negative infections was significantly lower than in Duffy-positive infections. P. vivax in Duffy-negative populations were not monophyletic, with P. vivax in Duffy-negative and Duffy-positive populations sharing similar DBP haplotypes and occurring in multiple, well-supported clades. Duffy-negative Africans are not resistant to P. vivax, and the public health significance of this should not be neglected. Our study highlights the need for a standardized approach and more resources/training directed towards the diagnosis of vivax malaria in Africa.

Metrics

1 Record Views
29 citations in Web of Science

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Infectious Diseases
Logo image